Ross Osborn
Stock Analyst at Cantor Fitzgerald
(0)
# 3327
Out of 5,240 analysts
103
Total ratings
34.12%
Success rate
1.82%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Exagen | Reiterates: Overweight | 8 8 | 3.02 | 164.9% | 5 | Jan 13, 2025 | |
Anteris Technologies | Initiates Coverage On: Overweight | 9 | 5.63 | 59.86% | 1 | Jan 7, 2025 | |
AVITA Medical | Reiterates: Overweight | 21 21 | 8.89 | 136.22% | 10 | Dec 24, 2024 | |
Nano X Imaging | Maintains: Overweight | 11 12 | 7.47 | 60.64% | 10 | Dec 6, 2024 | |
Prenetics Global | Reiterates: Overweight | 9 9 | 5.81 | 54.91% | 6 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 3 2 | 0.81 | 146.91% | 4 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 10 10 | 3 | 233.33% | 9 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 16 16 | 9.32 | 71.67% | 4 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 14 14 | 16.17 | -13.42% | 2 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 96 | 95.83 | 0.18% | 1 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 18 18 | 11.92 | 51.01% | 4 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 4 4 | 1.84 | 90.22% | 5 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 11 11 | 8.6 | 27.91% | 2 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 3 3 | 0.66 | 278.79% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 44 44 | 32.32 | 36.14% | 4 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 3 4 | 1.74 | 129.89% | 3 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 7 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 4 4 | 0.58 | 468.97% | 5 | Apr 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 5 | 2.89 | 73.01% | 2 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 25 25 | 15.63 | 59.95% | 7 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 12 12 | 18.23 | -34.17% | 2 | Jan 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 3 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 9 | 0.59 | 1359.32% | 2 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 27 21 | n/a | n/a | 2 | Apr 22, 2022 |